<i>MYORG</i> -related disease is associated with central pontine calcifications and atypical parkinsonism
Viorica Chelban(National Hospital for Neurology and Neurosurgery), Henry Houlden(Queen Mary University of London), Lucía Schottlaender(School of the Art Institute of Chicago), Gillian Rea(Belfast Health and Social Care Trust), Fatima Khan(The University of Texas Southwestern Medical Center), Stéphanie Efthymiou(Queen Mary University of London), Shahnaz Ibrahim(Aga Khan University Hospital), Farida Jan(National Hospital for Neurology and Neurosurgery), Davide Pareyson(Fondazione IRCCS Istituto Neurologico Carlo Besta), Salman Kirmani(Aga Khan University), Luca Magistrelli, Stanislav Groppa(National Hospital for Neurology and Neurosurgery), Jana Vandrovcová(Texas Tech University), Patrick J. Morrison(Belfast Health and Social Care Trust), Abdalla Bowirrat(Ariel University), Andrew J. Lees(Centre for Movement Disorders), Nicholas Wood(National Hospital for Neurology and Neurosurgery), Miryam Carecchio(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Bettina Balint(Heidelberg University), Ettore Salsano(Lucile Packard Children's Hospital), Luisa Chiapparini(Fondazione IRCCS Istituto Neurologico Carlo Besta), Kailash P. Bhatia(National Hospital for Neurology and Neurosurgery), Vincenzo Salpietro(University College London), Zul Qarnain(National Hospital for Neurology and Neurosurgery), Nin Bajaj(Nottingham University Hospitals NHS Trust), Barbara Garavaglia
Cited by 24
Related Papers
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE
|JNCI Journal of the National Cancer Institute|2013|946
Ensembl 2012
|Nucleic Acids Research|2011|839